Corbus Pharmaceuticals Holdings (CRBP) Other Accumulated Expenses (2014 - 2021)

Corbus Pharmaceuticals Holdings' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $1.7 million for Q4 2021.

• In Q4 2021, Other Accumulated Expenses rose 19.02% year-over-year to $1.7 million; the TTM figure through Dec 2021 stood at $1.7 million (up 19.02% YoY), while the FY2021 annual figure was $1.7 million, up 19.02% from the prior year.
• Other Accumulated Expenses was $1.7 million for Q4 2021 at Corbus Pharmaceuticals Holdings, up from $1.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q4 2021 to a low of $110446.0 in Q2 2017.
• Historically, Other Accumulated Expenses has averaged $921957.2 across 5 years, with a median of $953206.0 in 2019.
• The sharpest annual moves came in 2019 and 2021: Other Accumulated Expenses jumped 440.34% in 2019, then retreated 16.06% in 2021.
• A 5-year view of Other Accumulated Expenses shows it stood at $146609.0 in 2017, then surged by 214.17% to $460596.0 in 2018, then jumped by 108.19% to $958928.0 in 2019, then jumped by 52.35% to $1.5 million in 2020, then advanced by 19.02% to $1.7 million in 2021.
• The last three Other Accumulated Expenses figures came in at $1.7 million (Q4 2021), $1.4 million (Q3 2021), and $1.5 million (Q2 2021), per Business Quant data.